Damante G - Search Results

1

Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment.

Mio C, Bulotta S, Russo D, Damante G. Mio C, et al. Among authors: damante g. Cancers (Basel). 2019 Jan 9;11(1):61. doi: 10.3390/cancers11010061. Cancers (Basel). 2019. PMID: 30634442 Free PMC article. Review.

2

Nanoparticles Loaded with the BET Inhibitor JQ1 Block the Growth of Triple Negative Breast Cancer Cells In Vitro and In Vivo.

Maggisano V, Celano M, Malivindi R, Barone I, Cosco D, Mio C, Mignogna C, Panza S, Damante G, Fresta M, Andò S, Russo D, Catalano S, Bulotta S. Maggisano V, et al. Among authors: damante g. Cancers (Basel). 2019 Dec 30;12(1):91. doi: 10.3390/cancers12010091. Cancers (Basel). 2019. PMID: 31905936 Free PMC article.

3

Epigenetics of thyroid cancer and novel therapeutic targets.

Russo D, Damante G, Puxeddu E, Durante C, Filetti S. Russo D, et al. Among authors: damante g. J Mol Endocrinol. 2011 Apr 28;46(3):R73-81. doi: 10.1530/JME-10-0150. Print 2011 Jun. J Mol Endocrinol. 2011. PMID: 21325372 Review.

4

Targeting histone deacetylase in thyroid cancer.

Russo D, Durante C, Bulotta S, Puppin C, Puxeddu E, Filetti S, Damante G. Russo D, et al. Among authors: damante g. Expert Opin Ther Targets. 2013 Feb;17(2):179-93. doi: 10.1517/14728222.2013.740013. Epub 2012 Dec 13. Expert Opin Ther Targets. 2013. PMID: 23234477 Review.

5

Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.

D'Agostino M, Sponziello M, Puppin C, Celano M, Maggisano V, Baldan F, Biffoni M, Bulotta S, Durante C, Filetti S, Damante G, Russo D. D'Agostino M, et al. Among authors: damante g. J Mol Endocrinol. 2014 Jan 30;52(2):121-31. doi: 10.1530/JME-13-0160. Print 2014 Apr. J Mol Endocrinol. 2014. PMID: 24353283

6

MCM5 as a target of BET inhibitors in thyroid cancer cells.

Mio C, Lavarone E, Conzatti K, Baldan F, Toffoletto B, Puppin C, Filetti S, Durante C, Russo D, Orlacchio A, Di Cristofano A, Di Loreto C, Damante G. Mio C, et al. Among authors: damante g. Endocr Relat Cancer. 2016 Apr;23(4):335-47. doi: 10.1530/ERC-15-0322. Epub 2016 Feb 24. Endocr Relat Cancer. 2016. PMID: 26911376 Free PMC article.

7

Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer.

Celano M, Mio C, Sponziello M, Verrienti A, Bulotta S, Durante C, Damante G, Russo D. Celano M, et al. Among authors: damante g. Mol Cell Endocrinol. 2018 Jul 5;469:38-47. doi: 10.1016/j.mce.2017.05.036. Epub 2017 Jun 2. Mol Cell Endocrinol. 2018. PMID: 28579118 Review.

8

BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.

Mio C, Conzatti K, Baldan F, Allegri L, Sponziello M, Rosignolo F, Russo D, Filetti S, Damante G. Mio C, et al. Among authors: damante g. Oncol Rep. 2018 Feb;39(2):582-588. doi: 10.3892/or.2017.6152. Epub 2017 Dec 12. Oncol Rep. 2018. PMID: 29251329

9

Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.

Maggisano V, Celano M, Lepore SM, Sponziello M, Rosignolo F, Pecce V, Verrienti A, Baldan F, Mio C, Allegri L, Maranghi M, Falcone R, Damante G, Russo D, Bulotta S. Maggisano V, et al. Among authors: damante g. Endocrine. 2019 Mar;63(3):545-553. doi: 10.1007/s12020-018-01836-2. Epub 2019 Jan 19. Endocrine. 2019. PMID: 30661164

10

Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy.

Mio C, Damante G. Mio C, et al. Among authors: damante g. Biochim Biophys Acta Mol Basis Dis. 2022 Jun 1;1868(6):166390. doi: 10.1016/j.bbadis.2022.166390. Epub 2022 Mar 14. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 35296416 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

295 results

Search Page